Displaying drugs 8951 - 8975 of 9327 in total
Fenquizone
Experimental
Clopamide
Clopamide is an oral diuretic agent with antihypertensive activity. Like thiazide diuretics, it has an aromatic sulfonamide base but with no double-ring structure.
Experimental
Cyfluthrin
Experimental
Perphenazine enanthate
Experimental
Dubermatinib
Dubermatinib is under investigation in clinical trial NCT03572634 (Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL).
Investigational
4-hydroxybenzoyl-CoA
Experimental
4-(N,N-Dimethylamino)cinnamoyl-CoA
Experimental
Vedroprevir
Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
CHF-6333
Investigational
Zenarestat
Experimental
2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid
Experimental
Digalactosyl Diacyl Glycerol (Dgdg)
Experimental
7-(Carboxyamino)-8-Amino-Nonanoic Acid
Experimental
CHROMOPHORE (HIS-TYR-GLY)
Experimental
Methylecgonine
Experimental
Cannabinor
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Amibegron
Amibegron is an agonist for atypical beta3-adrenoceptors which inhibits intestinal motility.
Investigational
Laquinimod
Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod. It has been shown to reduce disease activity on magnetic resonance imaging and to be well...
Investigational
Displaying drugs 8951 - 8975 of 9327 in total